GLOBAL HEALTH - RESEARCH AND DEVELOPMENT PARTNERSHIPS

That this House pays tribute to the highly valuable and effective research and development (R&D) work into innovative global health goods carried out by public-private partnerships such as the European and Developing Countries Clinical Trials Partnership, the International AIDS Vaccine Alliance and the TB Alliance; highlights the important work these partnerships have done to accelerate the development of new or improved treatments, vaccines, microbicides, formulations and diagnostics against HIV/AIDS, tuberculosis and malaria with a focus on efficacy and implementation in affected regions such as sub-Saharan Africa; recognises that this work meets an urgent demand not currently met by market-based models of medical R&D and allows the integration and co-ordination of international research and the development of long-term medical research capacity in developing countries; and calls on the Government to maintain and employ its position as a leading funder of such partnerships to encourage increased contributions from other donor countries and private sector partners, particularly European Union member states.